Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia

Introduction. Bortezomib is a proteasome inhibitor indicated for the treatment of multiple myeloma patients. The most frequent side effects are gastrointestinal and neurological. Serious pulmonary complications have been described rarely. Observation. This case involves a 74-year-old man suffering f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vandeix, E., Favard, F., Pichon, N., Delage-Corre, M., Melloni, B., Clavel, M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2012
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3485493/
https://ncbi.nlm.nih.gov/pubmed/23133779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/430141
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak